- Name: Deanne Randolph
- Position: Executive Director
- Phone: (203) 635-0831
- Email: moc/skrowacm]ta[hplodnard
Most recently, Deanne led the European launch of Xiapex, an innovative first-in-class biologic for the treatment of Dupuytren’s Contracture, a rare fibroproliferative disorder, across 16 countries.
Deanne’s ability to integrate professional, payer and patient needs to identify compelling market strategies and drive growth is particularly relevant in today’s dynamic healthcare environment. She has worked in both primary and secondary care across a broad range of therapeutic areas, including hematology, oncology, pain/inflammation and rare diseases.
Prior to consulting, Deanne held brand management and commercial development positions at Pfizer, Johnson & Johnson and Bayer.
Deanne holds both an M.B.A. and a B.A. from Wake Forest University.